Engineered in India - Patent law 2.0

India is known as the “pharmacy of the developing world,” because it supplies much of the world's demand for affordable, generic drugs. So when the Supreme Court of India issued a landmark ruling in April adopting a strict interpretation of the country's new patent law, advocates for global access to medicines celebrated. In fact, the decision in Novartis v. Union of India & Others provides an important model for other countries around the world — a step toward a “patent law 2.0” that not only helps to ensure access to medicines but might also help better align pharmaceutical innovation with public health needs.